Zoll Circulation, Inc., a subsidiary of Asahi Kasei Corp., is an American company. The firm manufactures cardiac resuscitation devices.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Mentice AB provides software and hardware simulation solutions for endovascular therapies. Its engages in healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. The firms solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. It operates through the following segments: Teaching Entities, Healthcare Systems, and Medical Device Industry. The Teaching Entities segment is used for educating, training, and accrediting medical students and surgeons in their academic research. The Healthcare Systems segment includes all healthcare entities outside of academic and university hospital settings. The Medical Device industry segment consists of global providers of products where simulation solutions can be integrated to fit specific patient needs. It also includes solutions for training, sales, and marketing, research and clinical evaluation. The company was founded in 1999 and is headquartered in Gothenburg, Sweden.

Edwards Lifesciences AG, a subsidiary of Edwards Lifesciences Corp., is a Swiss company located in Nyon that manufactures and distributes healthcare equipment.

Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of Cardiovascular Diseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling. Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention. The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.

Marblehead Medical LLC provides health care services. The company was founded by Waleed Brinjikji and David Kallmes and is headquartered in Rochester, MN.

Epitome Pharmaceuticals identifies, develops and licenses promising medications and technologies. Investigation is conducted by reading the scientific literature, discussing anomalies and questions with leaders in their fields, and by statistical reanalysis of published data. Once a remedy has been identified and intellectual property rights secured, they proceed to advance the development of the medication. They clarify regulatory issues through close cooperation with regulatory agencies. Based on their research and the prospects for a specific medication, they may file an IND and initiate Phase I or Phase II trials. Ultimately, Epitome Pharmaceuticals seeks to license its intellectual property to a partner (or partners) with the resources and capabilities to complete clinical trials, secure regulatory approval and bring a product to market most effectively.

Founded by George Wallace and Andy Cragg, Intersect Partners LLC is a research incubator and venture capital firm located in San Clemente, California

Suzhou Aijikang Biotechnology Co., Ltd., established on 2014-08-18, Business scope includes biotechnology development;research and development,Sales:bed linings,Office Supplies,furniture,Auto Accessories,medical instruments.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhengzhou Meigang Hi-Tech Biotechnology Co., Ltd., established on 2018-11-12, Business scope includes biotechnology research and development;Ikind,Class II,Class III medical device,medicalXX-ray and magnetic resonance equipment,Medical nuclide equipment,Biological product,Medical polymer materials and products,Intervention equipment,implant material,software,Technical research and development of tissue engineering products,technical consulting,Technical Services,technology transfer;Health Management Consulting;Biomedical and medical information consultation;Sales:Instrumentation,biologics,Medical electronic equipment,medicine,Ikind,Class II,Class III medical device;Import and export of goods or technology.

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders.\nCoAxia was founded in 1999 by Denise Barbut MD.

Arteria Medical Science, Inc. develops Parodi Anti-Emboli System and other medical devices. The company is headquartered in San Francisco, CA.

Tencent America LLC engages in providing Internet and gaming services. The company is headquartered in Palo Alto, CA.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

MicroPort NeuroTech is a medical device company that specializes in neurological intervention. It develops innovative products that deliver safe, effective, and accurate solutions for patients with cerebrovascular diseases. MicroPort NeuroTech's unique products include WILLIS Intracranial Stent Graft System, APOLLO Intracranial Stent System, and Tubridge Vascular Reconstruction Device for treatments. The products promote therapeutic options adapted to specific needs. MicroPort NeuroTech was founded on May 2012 and is based in Shanghai, China.

Nan Tong Dong Hu Guo Ji Shang Wu Fu Wu You Xian Gong Si, established on 2017-03-02, Business scope includes general items:Business agency service;Conference and Exhibition Services;Advertising Design,acting;advertisement making;advertising;Leisure and sightseeing activities;sales agent(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

KBIC offers a platform of networking for about businesses and institutes in their pursuit of innovative collaboration and groundbreaking discoveries in a wide spectrum of medical, pharmaceutical, and biological fields, including the medical device and regenerative medical fields. KBIC’s foremost mission is to enhance human health and vitalize the global healthcare industry through collaborative ties between and among those in the business, academic, governmental and healthcare sectors.

Suzhou Ai Ruide Medical Technology Co., Ltd., established on 2012-07-26, Business scope includes research and development of medical devices;Production:medical instruments;medical instruments,Technology development in the field of biomedicine,technology transfer,technical consulting,Technical Services;Enterprise Marketing Planning;market research;Business Consulting,Business Management Consulting Services;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenyang Hengde Medical Device R&D Co., Ltd., established on 2008-08-19, Business scope includes licensed projects:Production of Class II Medical Devices,Production of sterile equipment,Internet Information Service for Medical Devices,The first type of value-added telecommunications services,The second type of value-added telecommunications services,Disinfectant production(Free of Hazardous Chemicals),Disinfection equipment sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:software development,Research and Development of Household Appliances,Household Appliance Manufacturing,Home Appliance Sales,Sales of Class II Medical Devices,Disinfectant sales(Free of Hazardous Chemicals),Manufacture of special equipment for environmental protection,Environmental protection special equipment sales,software sales,Research and development of intelligent robots,Intelligent robot sales,Data processing and storage support services,data processing services,Information Technology Consulting Services,Digital Technology Services,Class II Medical Device Leasing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)